Target intelligence / Profile preview

Potassium ion homeostasis pathway

Molecular classification
Ion channel, Transporter, Pumping ATPase
01

Overview

Potassium ion homeostasis pathway refers to the complex physiological processes that maintain the concentration of potassium ions (K+) within a narrow range in the extracellular and intracellular compartments (StatPearls, 2023 [4]). This regulation is critical for maintaining the resting membrane potential of cells, which is essential for the proper functioning of excitable tissues such as the heart, nerves, and muscles (Nature Reviews Nephrology, 2017 [5]). The pathway involves a coordinated effort between the kidneys, which are responsible for the majority of potassium excretion, and the gastrointestinal tract, as well as the shifting of potassium between fluid compartments mediated by the Na+/K+-ATPase pump (PubMed, 2016 [1]). Dysregulation of this pathway leads to clinical conditions such as hyperkalemia or hypokalemia, both of which can cause lethal cardiac arrhythmias (NIH, 2022 [6]). Therapeutic intervention often targets specific components of the pathway, including renal ion channels (e.g., ROMK), transporters (e.g., NCC), or the use of gastrointestinal potassium binders to manage systemic levels (Clinical Journal of the American Society of Nephrology, 2017 [3]).

Other names
Potassium balanceK+ homeostasisRenal potassium handlingPotassium regulation
02

Mechanism of action

Drugs targeting this pathway act by inhibiting or activating specific ion channels (e.g., ROMK, BK), transporters (e.g., NCC, NKCC2), or pumps (Na+/K+-ATPase) to alter the renal excretion, intestinal absorption, or cellular distribution of potassium ions (Palmer & Clegg, 2016 [1]).

03

Biological functions

Regulation of membrane potentialOsmotic pressure regulationAcid-base balanceCardiac conductionNeuromuscular function
04

Disease associations

HyperkalemiaHypokalemiaHypertensionCardiac arrhythmiaChronic kidney diseaseBartter syndromeGitelman syndrome
05

Safety considerations

Risk of sudden cardiac arrest due to arrhythmiasRenal impairmentMetabolic acidosis or alkalosisDrug-drug interactions with ACE inhibitors or ARBs
06

Interacting drugs

Spironolactone

7 more in the full profile.

07

Biomarkers

Serum potassium concentrationTranstubular potassium gradient (TTKG)Electrocardiogram (ECG) patternsUrinary potassium-to-creatinine ratio

Beyond the preview

Go deeper on Potassium ion homeostasis pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium ion homeostasis pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call